111 related articles for article (PubMed ID: 6800426)
1. [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Chauvergne J; Durand M; Brunet R; Bui BN; Hoerni B; Mauriac L
Bull Cancer; 1981; 68(5):442-8. PubMed ID: 6800426
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Garewal HS; Brooks RJ; Jones SE; Miller TP
J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
[TBL] [Abstract][Full Text] [Related]
3. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N
Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640
[TBL] [Abstract][Full Text] [Related]
4. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
5. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D
Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336
[TBL] [Abstract][Full Text] [Related]
6. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
Lagler U; Gattiker HH
Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
Denefrio JM; East DR; Troner MB; Vogel CL
Cancer Treat Rep; 1978 Dec; 62(12):2113-5. PubMed ID: 751719
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
DiStefano A; Yap HY; Blumenschein GR
Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
[TBL] [Abstract][Full Text] [Related]
9. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of VM 26, mitomycine C and methotrexate in advanced breast cancer refractory to a four drug combination (author's transl)].
Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H
Bull Cancer; 1979; 66(5):485-90. PubMed ID: 554673
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
12. [Intra-arterial chemotherapy in locally advanced or recurrent breast neoplasms].
Morandi C; Colopi S; Cantore M; Molani L; Calzona C; Reggiani G; Amadori M; Smerieri F; Pellecchi G
Radiol Med; 1996; 92(1-2):101-4. PubMed ID: 8966246
[TBL] [Abstract][Full Text] [Related]
13. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Zhang X; Sun Y; Feng F
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin-associated lung disease.
Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
[No Abstract] [Full Text] [Related]
16. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
17. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
[TBL] [Abstract][Full Text] [Related]
18. Vindesine. A phase II trial in advanced breast cancer patients.
Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
